Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) were down 9.6% on Friday after Canaccord Genuity Group lowered their price target on the stock from $57.00 to $56.00.

Baird, a prominent analyst firm, maintained an outperform rating on AdaptHealth, but reduced the stock's price target to $14.00 from $16.00, citing concerns over the company's struggling Diabetes ...

The firm maintains a Buy rating on the stock despite anticipating a delay in the emergence of catalysts that could drive the share price higher. The adjustment follows the recognition that AdaptHealth ...

Patients are stuck in a loop between pharmacies and doctors trying to fill prescriptions for vital medicines which are frequently out of stock ... containing fentanyl, diabetes drug Ozempic ...

Eggs are a nutrient-rich food that can be a healthy part of your diet if you have diabetes. While they’re high in dietary cholesterol, this has a much smaller effect than foods high in saturated ...

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide ...

For some people living with diabetes, blood sugar can drop or rise overnight, interrupting sleep. Difficulty sleeping can also affect your insulin. But there are things you can do to manage blood ...

Canadians living with type 2 diabetes agree that uplifting words, positive feedback and supportive tools are the most powerful motivators MISSISSAUGA, ON, Oct. 30, 2024 /CNW/ -- Abbott (NYSE: ABT) ...